Inivata develops a noninvasive liquid biopsy diagnostic using the precision of circulating tumor DNA (ctDNA) analysis for improving cancer detection and assessing individual response to treatment.
Employment range in NC
Primary site activity
All company activities
Products on market
InVisionFirst-Lung; RaDaR assay
Products under development
ctDNA assay, a simple blood test for detecting cancer, stratifying patients, and assessing individual response to treatment.